Cannabis Technologies Looks to Capitalize on Therapeutics

The U.S. medical marijuana industry has grown at a 16.2% CAGR between 2009 and 2014 to generate $2 billion in annual revenue, according to┬áIBIS World. With over 1.4 million businesses and a growing number of public companies in the space, investors have a number of options when looking to gain exposure, ranging from large firms…

The post Cannabis Technologies Looks to Capitalize on Therapeutics appeared first on Marijuana Index.